Angiotensin II and L-arginine in tissue fibrosis: More than blood pressure

Kidney International

Volumn 51, Issue 5, 1997, Pages 1481-1486

  Peters, H ^a   Noble, N A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ARGININE;

GLOMERULUS FILTRATION; KIDNEY FIBROSIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW; RISK FACTOR; TISSUE REPAIR;

EID: 0030949440     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.203     Document Type: Article

References (63)

1. W.A. Border N.A. Noble Transforming growth factor- β in tissue fibrosis N Engl J Med 331 1994 1286 1292
2. W.A. Border S. Okuda L.R. Languino M.B. Sporn E. Ruoslahti Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta-1 Nature 346 1990 371 374
3. W.A. Border N.A. Noble T. Yamamoto Harper Jr Y. Yamaguchi M.D. Pierschbacher E. Ruoslahti Natural inhibitor of transforming growth factor- β protects against scarring in experimental kidney disease Nature 360 1992 361 364
4. E.J. Lewis L.G. Hunsicker R.P. Bain R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
5. D.C. Cattran C. Greenwood S. Ritchie Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy Am J Kidney Dis 23 1994 247 254
6. J.B. Rosman P.M. ter-Wee S. Meijer T.P. Piers-Becht W.J. Sluiter A.J. Donker Prospective randomised trial of early dietary protein restriction in chronic renal failure Lancet 2 1984 1291 1296
7. A.S. Levey S. Adler A.W. Caggiula B.K. England T. Greene L.G. Hunsicker J.W. Kusek N.L. Rogers P.E. Teschan Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study Am J Kidney Dis 27 1996 652 663
8. C. Wislon F.B. Byrom The vicious circle in chronic Bright's disease: Experimental evidence from the hypertensive rat Q J Med 10 1940 65 96
9. R.J. Johnson C.E. Alpers A. Yoshimura D. Lombardi P. Pritzl J. Floege S.M. Schwartz Renal injury from angiotensin II-mediated hypertension Hypertension 19 1992 464 474
10. M.E. Rosenberg L.J. Smith R. Correa Rotter T.H. Hostetter The paradox of the renin-angiotensin system in chronic renal disease Kidney Int 45 1994 403 410
11. S. Anderson H.G. Rennke B.M. Brenner Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 77 1986 1993 2000
12. W.F. Ward A. Molteni C.-H. Ts'ao J.M. Hinz Captopril reduces collagen and mast cell accumulation in irradiated rat lund Int J Radiat Oncol Biol Phys 19 1990 1405 1409
13. S.G. Ramos A.P. Montenegro G. Goissis M.A. Rossi Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis Pathol Int 44 1994 655 661
14. G. Wolf U. Haberstroh E.G. Neilson Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells Am J Pathol 95 1992 107 140
15. H. Itoh M. Mukoyama R.E. Pratt G.H. Gibbons V.J. Dzau Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II J Clin Invest 91 1993 2268 2274
16. S. Kagami W.A. Border D.E. Miller N.A. Noble Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor- β expression in rat glomerular mesangial cells J Clin Invest 93 1994 2431 2437
17. J.A. Olson Jr K.T. Shiverick S. Ogilvie W.C. Buhi M.K. Raizada Angiotensin II induces secretion of plasminogen activator inhibitor 1 and a tissue metalloprotease inhibitor-related protein from rat brain astrocytes Proc Natl Acad Sci USA 88 1991 1928 1932
18. B. Zelezna B. Rydzewski D. Lu J.A. Olson K.T. Shiverick W. Tang C. Sumners M.K. Raizada Angiotensin-II induction of plasminogen activator inhibitor-1 gene expression in astroglial cells of normotensive and spontaneously hypertensive rat brain Mol Endocrinol 6 1992 2009 2017
19. E.P. Feener J.M. Northrup L.P. Aiello G.L. King Angiotensin II induces plasminogen activator-1 and -2 expression in vascular endo thelial and smooth muscle cells J Clin Invest 95 1995 1353 1362
20. W.H. Baricos S.L. Cortez S.S. El Dahr H.W. Schnaper ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade Kidney Int 47 1995 1039 1047
21. D.T. Eitzman R.D. McCoy X. Zheng W.P. Fay T. Shen D. Ginsburg R.H. Simon Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack of overexpress the murine plasminogen activator inhibitor-1 gene J Clin Invest 97 1996 232 237
22. S. Tomooka W.A. Border B.C. Marshall N.A. Noble Glomerular matrix accumulation is linked to inhibition of the plasmin protease system Kidney Int 42 1992 1462 1469
23. Kagami S, Kuhara T, Okada K, Kuroda Y, Border WA, Noble NA: Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int (in press)
24. B.M. Brenner T.W. Meyer T.H. Hostetter Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progres sive glomerular sclerosis in aging, renal ablation and intrinsic renal disease N Engl J Med 307 1982 652 659
25. T.H. Hostetter T.W. Meyer H.G. Rennke B.M. Brenner J.A. Noddin D.J. Sandstrom Chronic effects of dietary protein in the rat with intact and reduced renal mass Kidney Int 30 1986 509 517
26. T.W. Meyer S. Anderson H.G. Rennke B.M. Brenner Reversing glomerular hypertension stabilizes established glomerular injury Kid ney Int 31 1987 752 759
27. S. Klahr A.S. Levey G.J. Beck A.W. Caggiula L. Hunsicker J.W. Kusek G. Striker The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modifi cation of Diet in Renal Disease Study Group N Engl J Med 330 1994 877 884
28. S. Klahr Role of dietary protein and blood pressure in the progres sion of renal disease Kidney Int 49 1996 1783 1786
29. R.C. Blantz F.B. Gabbai B.J. Tucker T.Y. Yamamoto C.B. Wilson Role of mesangial cell in glomerular response to volume and angio tensin II Am J Physiol 264 1993 F158 F165
30. C.G. Pan B.A. Bresnahan C.R. Albrightson D. Griswold E.A. Lianos Cytokine inhibition preserves renal hemodynamic function following mesangial cell immune injury Invest Med 44 1996 375 381
31. S. Okuda T. Nakamura T. Yamamoto E. Ruoslahti W.A. Border Dietary protein restriction rapidly reduces transforming growth factor b1 expression in experimental glomerulonephritis Proc Natl Acad Sci USA 88 1991 9765 9769
32. A.A. Eddy Protein restriction reduces transforming growth factor- β and interstitial fibrosis in nephrotic syndrome Am J Physiol 266 1994 F884 F893
33. M. Fukui T. Nakamura I. Ebihara I. Nagaoka Y. Tomino H. Koide Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor- β in experimen tal glomerular sclerosis J Lab Clin Med 121 1993 224 234
34. S. Moncada A. Higgs The L-arginine-nitric oxide pathway N Engl J Med 329 1993 2002 2012
35. M.S. Mulligan J.M. Hevel M.A. Marletta P.A. Ward Tissue injury caused by deposition of immune complexes is L-arginine dependent Proc Natl Acad Sci USA 88 1991 6338 6342
36. N. McCartney-Francis J.B. Allen D.E. Mizel J.E. Albina Q. Zie C.F. Nathan S.M. Wahl Suppression of arthritis by an inhibitor of nitric oxide synthase J Exp Med 178 1993 749 754
37. G-monomethyl-L-arginine J Exp Med 179 1994 651 660
38. V.E. Shih Regulation of ornithine metabolism Enzyme 26 1981 254 258
39. J.E. Eastoe Compositon of collagen and allied proteins G.N. Ramachandran Treatise on Collagen I. Chemistry of Collagen 1967 Academic Press, Inc. New York 1
40. W.C. Rose The nutritive significance of the amino acids and certain related compounds Science 86 1937 298 300
41. O. Levillain A. Hus-Citharel F. Morel L. Bankier Localization of arginine synthesis along rat nephron Am J Physiol 259 1991 F916 F923
42. S.N. Dhanakoti J.T. Brosnan G.R. Herzberg M.E. Brosnan Renal arginine synthesis: Studies in vitro and in vivo Am J Physiol 259 1990 E437 E442
43. W.R. Featherston Q.R. Rogers R.A. Freeland Relative importance of kidney and liver in synthesis of arginine by the rat Am J Physiol 224 1973 127 129
44. E. Seifter G. Rettura A. Barbul S.M. Levenson Arginine: An essential amino acid for injured rats Surgery 84 1978 224 230
45. J.E. Albina C.D. Mills A. Barbul C.E. Thirkill W.L. Henry Jr B. Mastrofrancesco M.D. Caldwell Arginine metabolism in wounds Am J Physiol (Endocrinol Metab) 254 1988 E459 E467
46. H.T. Cook A. Jansen S. Lewis P. Largen M. Donald D. Reaveley V. Cattell Arginine metabolism in experimental glomerulonephritis: Interaction between nitric oxide synthase and arginase Am J Physiol 267 1994 F646 F653
47. V. Cattell T. Cook S. Moncada Glomeruli synthesize nitrite in experimental nephrotoxic nephritis Kidney Int 38 1990 1056 1060
48. V. Cattell P. Largen E. de Heer T. Cook Glomeruli synthesize nitrite in active Heymann nephritis; the source is infiltrating macro phages Kidney Int 40 1991 847 851
49. V. Cattell E. Lianos P. Largen T. Cook Glomerular NO synthase activity in mesangial cell immune injury Exp Nephrol 1 1993 36 40
50. M. Ketteler N. Ikegaya D.K. Brees W.A. Border N.A. Noble L-arginine metabolism in immune-mediated glomerulonephritis in the rat Am J Kidney Dis 50 1996 878 887
51. I. Narita W.A. Border M. Ketteler N.A. Noble Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis Lab Invest 72 1995 17 24
52. I. Narita W.A. Border M. Ketteler E. Ruoslahti N.A. Noble L-arginine may mediate the therapeutic effects of low protein diets Proc Natl Acad Sci USA 92 1995 4552 4556
53. A. Junaid M.E. Rosenberg T.H. Hostetter Interaction of angioten sin II (AII) and transforming growth factor beta (TGF- β ) in the remnant kidney J Am Soc Nephrol 4 1993 772 (abstract)
54. S. Kim K. Ohta A. Hamaguchi T. Omura T. Yukimura K. Miura Y. Inada T. Wada Y. Ishimura F. Chatani H. Iwao Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats Hypertension 24 1994 195 204
55. K. Ohta S. Kim A. Hamaguchi T. Yukimura K. Miura K. Takaori H. Iwao Role of angiotensin II in extracellular matrix and transform ing growth factor- β 1 expression in hypertensive rats Eur J Pharmacol 269 1994 115 119
56. S.J. Shankland H. Ly K. Thai J.W. Scholey Increased glomerular capillary pressure alters glomerular cytokine expression Circ Res 75 1994 844 853
57. S. Kim K. Ohta A. Hamaguchi T. Omura T. Yukimura K. Miura Y. Inada T. Wada Y. Ishimura F. Chatani H. Iwao Contribution of renal angiotensin II type 1 receptor to gene expressions in hypertension-induced renal injury Kidney Int 46 1994 1346 1358
58. M. Nishimura M. Okamura Y. Konishi K. Inoue C.K. Young T. Yoshioka N. Negoro T. Inoue Y. Kanayama Effect of treatment with ACE inhibitor (ACEI) on TGF-Beta gene expressions in renal biopsy from patients with IgA nephropathy J Am Soc Nephrol 6 1995 397 (abstract)
59. J.L. Pimentel Jr C.L. Sundell S. Wang J.B. Kopp A. Montero M. Martinez-Maldonado Role of angiotensin II in the expression and regulation of transforming growth factor- β in obstructive ne phropathy Kidney Int 48 1995 1233 1246
60. M. Ruiz-Ortega S. Gonzalez D. Seron E. Condom C. Bustos R. Largo E. Gonzalez A. Ortiz J. Egido ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis Kidney Int 48 1995 1778 1891
61. F.S. Shihab T. Andoh A. Tanner W.M. Bennett Angiotensin II (All) blockade ameliorates fibrosis and decreases TGF- β 1 expression in chronic cyclosporine (CsA) nephropathy J Am Soc Nephrol 7 1996 1846 (abstract)
62. S. Ishidoya J. Morrissey R. McCracken S. Klahr Delayed treat ment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy Kidney Int 49 1996 1110 1119
63. T. Yamamoto N.A. Noble D.E. Miller W.A. Border Sustained expression of TGF- β 1 underlies development of progressive kidney fibrosis Kidney Int 45 1994 916 927